Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) is now available.
Daito Pharmaceutical Co., Ltd. reported a 5.6% increase in net sales for the nine months ending February 28, 2025, compared to the previous year. However, the company experienced a significant decline in profits, with operating profit down by 39.8% and ordinary profit by 34.9%. The financial results indicate challenges in maintaining profitability despite increased sales, which may impact the company’s strategic positioning and stakeholder confidence.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. The company is involved in the development, manufacturing, and distribution of pharmaceutical products, focusing on providing healthcare solutions in the Japanese market.
YTD Price Performance: 1.96%
Average Trading Volume: 34,705
Technical Sentiment Signal: Hold
Current Market Cap: Yen32.7B
Learn more about 4577 stock on TipRanks’ Stock Analysis page.